<< Start < Next > End >>

Page 127 of 4


BioMedReports Aldeyra Provides Update on NS2 Clinical Program; Acasti Receives Full Data for Phase II TRIFECTA Trial: Below ... http://t.co/3S9al6m6nS
BioMedReports FDA Approves a New Sanofi Diabetes Drug, But How Much Will it Matter?... http://t.co/78EbjQBWyh
BioMedReports Acasti Gains Ahead Of Expected Phase II Results; Cyberonics Plans To Merge With Milan's Sorin SpA: Below is a ... http://t.co/oi5KPKbAAT